AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

Abivax has reported positive topline results from Part 2 of [...]

Amorphical has announced positive final long-term results from its Phase [...]

Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]

The National Institute for Health and Care Excellence (NICE) has [...]